Rahsaan Thompson
Direktor/Vorstandsmitglied bei Oakland Museum of California
Aktive Positionen von Rahsaan Thompson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Oakland Museum of California | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Rahsaan Thompson
Ehemalige bekannte Positionen von Rahsaan Thompson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LYELL IMMUNOPHARMA, INC. | General Counsel | 28.09.2022 | 16.06.2023 |
MCKESSON CORPORATION | General Counsel | - | - |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | General Counsel | - | - |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | General Counsel | - | - |
GRITSTONE BIO, INC. | General Counsel | 06.04.2020 | - |
OPIANT PHARMACEUTICALS, INC. | General Counsel | 16.09.2019 | - |
Ausbildung von Rahsaan Thompson
Southern Methodist University | Undergraduate Degree |
Hofstra University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Operativ
General Counsel | 6 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
GRITSTONE BIO, INC. | Health Technology |
MCKESSON CORPORATION | Distribution Services |
LYELL IMMUNOPHARMA, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
Oakland Museum of California | |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
- Börse
- Insiders
- Rahsaan Thompson
- Erfahrung